Zymeworks Inc (NYSE:ZYME)
| 42.00 Delayed Data As of Dec 13 |  -0.86 / -2.01%Today’s Change | 10.72 Today|||52-Week Range 45.58 | +186.10% Year-to-Date |
Latest ZYME News | Press Releases
No recent news for Zymeworks Inc.
Today’s Trading
| Previous close | 42.86 |
| Today’s open | 43.08 |
| Day’s range | 41.69 - 43.50 |
| Volume | 318,180 |
| Average volume (3 months) | 304,796 |
| Market cap | $1.7B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | -146.41% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +49.52% |
| Revenue growth (last year) | +2.43% |
| P/E ratio | NM |
| Price/Sales | 8.05 |
| Price/Book | 7.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GOSSGossamer Bio Inc | -0.26 | -1.01% |
| FTSVForty Seven Inc | -2.99 | -7.72% |
| APLSApellis Pharmaceutic... | +0.41 | +1.50% |
| PRNBPrincipia Biopharma ... | +0.18 | +0.36% |
Data as of 4:00pm ET, 12/13/2019
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $53.0M |
| Annual profit (last year) | -$36.6M |
| Net profit margin | -68.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Vancouver, British Columbia |
Forecasts
